Latest filing published 15 Dec 2023 for TransMedics Group, Inc., €6,203.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Miriam Provost: trading record in brief
All filings by Miriam Provost on record concern TransMedics Group, Inc., in the capacity of senior executive. We count 24 filings; the first trade dates from 11 December 2020 and the latest from 15 December 2023.
No open-market purchase appears, only 9 sales worth €1.0M. The rest of the record consists of 1 share grant and 13 option exercises. Since January 2023: no purchases and 4 sales on the market.
On 15 December 2023 came the latest disclosure, an open-market sale for €14k in TransMedics Group, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Miriam Provost
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 415 shares@ US$16.141.5% of flowCommon StockSEC:0000950170-23-070835:0
- 1,785 shares@ US$3.221.3% of flowCommon StockSEC:0000950170-23-046432:0
- 5,685 shares0Common StockSEC:0000899243-23-005899:0
- 5,918 shares@ US$38.4653.1% of flowCommon StockSEC:0000899243-22-038601:0
- 2,600 shares@ US$3.222.1% of flowCommon StockSEC:0000899243-22-038318:0
- 884 shares@ US$3.220.8% of flowCommon StockSEC:0000899243-21-049930:0
- 5,625 shares@ US$16.1423.9% of flowCommon StockSEC:0000899243-21-036415:0
- 2,206 shares@ US$3.221.9% of flowCommon StockSEC:0000899243-21-031299:0
8 of 8 declarations
